Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Daiichi Sankyo
Boehringer Ingelheim
McKinsey
Accenture
Merck
Covington
Argus Health
Fuji
Queensland Health

Generated: October 19, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,754,070

« Back to Dashboard

Which drugs does patent 8,754,070 protect, and when does it expire?


Patent 8,754,070 protects ANDROGEL and is included in one NDA. There have been three Paragraph IV challenges on Androgel.

This patent has twenty-seven patent family members in twenty-five countries.

Summary for Patent: 8,754,070

Title:Testosterone gel and method of use
Abstract: The present invention relates to an improved transdermal hydroalcoholic testosterone gel formulation that provides, among other things, a desirable pharmacokinetic hormone profile, and methods of use.
Inventor(s): Malladi; Ramana (Marietta, GA), Stahlman; Jodi (Smyrna, GA)
Assignee: Unimed Pharmaceuticals, LLC (Marietta, GA) Besins Healthcare Luxembourg SARL (Charlotte, LU)
Application Number:13/831,217
Patent Claim Types:
see list of patent claims
Composition; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Abbvie
ANDROGEL
testosterone
GEL, METERED;TRANSDERMAL022309-001Apr 29, 2011ABRXYesYes► Subscribe► SubscribeY
Abbvie
ANDROGEL
testosterone
GEL;TRANSDERMAL022309-002Sep 7, 2012AB2RXYesNo► Subscribe► SubscribeY
Abbvie
ANDROGEL
testosterone
GEL;TRANSDERMAL022309-003Sep 7, 2012AB2RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 8,754,070

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,729,057Testosterone gel and method of use► Subscribe
8,466,136Testosterone gel and method of use► Subscribe
8,466,138Testosterone gel and method of use► Subscribe
8,486,925Testosterone gel and method of use► Subscribe
8,741,881Testosterone gel and method of use► Subscribe
8,466,137Testosterone gel and method of use► Subscribe
8,759,329Testosterone gel and method of use► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,754,070

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Norway20082170► Subscribe
Morocco29941► Subscribe
Japan5728508► Subscribe
South Korea20080068654► Subscribe
Japan2013064028► Subscribe
Japan5584415► Subscribe
Japan2009511602► Subscribe
Israel190522► Subscribe
CroatiaP20130071► Subscribe
Hong Kong1117417► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Chubb
Healthtrust
McKinsey
Cipla
Chinese Patent Office
Farmers Insurance
US Department of Justice
Express Scripts
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot